DLEU2 and central nervous system cancer: For example, lncRNA MALAT1/miR-199a/ZHX1 axis suppresses glioblastoma proliferation and progression, and lncRNA-DLEU2/miR-186-5p/PDK3 axis advances glioma cell progression [21].